Calgary Scientific’s Global Installed Base Tops 30 Countries
CALGARY, Alberta Calgary Scientific Inc., a company known for creating transformative technology for the medical industry and beyond, announced today they have completed successful installations in...
View ArticleEHOB Opens Company’s First International Office in China
INDIANAPOLIS EHOB, a leading provider of affordable products effective in the prevention and treatment of pressure ulcers, announces today the opening of its first international office in China....
View ArticleMauna Kea Technologies: Major Success for Cellvizio at the EUS 2014 Conference
PARIS Regulatory News: Mauna Kea Technologies (Paris:MKEA) (NYSE Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the only trans-disciplinary optical biopsy platform, today announced that...
View ArticleNeuroMetrix CEO to Present at 29th Annual Meeting of Japan Society of...
WALTHAM, Mass. NeuroMetrix, Inc. (Nasdaq: NURO), today announced that Shai N. Gozani M.D., Ph.D., NeuroMetrix President and Chief Executive Officer, will participate in the 29th Annual Meeting of...
View ArticleGilead Submits New Drug Application to Japan’s Pharmaceutical and Medical...
FOSTER CITY, Calif. Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company has submitted a New Drug Application (NDA) to Japan’s Pharmaceutical and Medical Devices Agency (PMDA) for...
View ArticleU.S. FDA Accepts Otsuka and Lundbeck’s Filing for Review of Brexpiprazole for...
TOKYO, Japan & VALBY, Denmark Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced that the U.S. Food and Drug Administration (FDA) has determined that the New...
View ArticleToshiba Announces Business Vision for Southeast Asia
JAKARTA, Indonesia Mr. Hisao Tanaka, the President and CEO of Japan’s Toshiba Corporation (TOKYO:6502), today announced Toshiba’s comprehensive strategy for expanding its business in Southeast Asia,...
View ArticleDr. Reddy’s Announces the Launch of LEVALBUTEROL INHALATION SOLUTION, USP
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Levalbuterol Inhalation Solution, USP 0.31 mg /3 mL, 0.63 mg /3 mL, 1.25 mg / 3 mL Unit-Dose Vials, a...
View Article東芝:NFC Tag機能を搭載したBluetoothⓇ Smart機器向けICの製品化について
東京 (ビジネスワイヤ) — 東芝は、BluetoothⓇ low energy通信方式注1と、NFC Forum Type 3 Tag規格に準拠した通信方式を兼ね備えたIC「TC35670FTG」を製品化し、本日からサンプル出荷を開始します。 東芝:NFC Tag機能を搭載したBluetooth(R) Smart機器向けIC「TC35670FTG」(写真:ビジネスワイヤ)...
View ArticleToshiba Launches Low Power Consumption ICs for Bluetooth® Smart Communication...
TOKYO Toshiba Corporation (TOKYO:6502) today announced the launch of “TC35670FTG”, a low power consumption dual function IC that supports both Bluetooth® Low Energy (LE)[1] communications and NFC...
View ArticleBaxter and Merrimack Pharmaceuticals Enter into Exclusive Ex-U.S. Licensing...
DEERFIELD, Ill. & CAMBRIDGE, Mass. Baxter International Inc. (NYSE:BAX) and Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today jointly announced an exclusive license and collaboration agreement...
View Article东芝宣布在东南亚地区的业务愿景
印尼雅加达 (美国商业资讯)–日本东芝公司(Toshiba Corporation, TOKYO:6502)总裁兼首席执行官Hisao Tanaka先生今天宣布了该公司扩大东南亚业务的综合战略,包括在未来5年内向该区域投资10亿美元,以及实现其销售额在现有基础上翻番的目标,达到70亿美元。...
View ArticleBlaze Bioscience Announces Initiation of Phase 1b Brain Cancer Program for...
SEATTLE Blaze Bioscience, Inc., a biotechnology company focused on guided cancer therapy, announced today that the company has received clearance from the United States Food and Drug Administration...
View Article东芝推出适用于带NFC标签功能蓝牙智能通信设备的低功耗集成电路
东京 (美国商业资讯)–东芝公司(Toshiba Corporation) (TOKYO:6502)今天宣布推出“TC35670FTG”,这是一款支持低功耗(LE)蓝牙(Bluetooth®) [1]通信和近场通信(NFC) Type 3标签的低功耗双重功能集成电路(IC)。样品出货即日启动。 Toshiba launches low power consumption ICs...
View ArticleNovaBay Receives First Large NeutroPhase Order From China Pioneer Pharma
EMERYVILLE, Calif. NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, today...
View ArticleEPIRUS and Livzon Mabpharm, Inc. Enter Collaboration Agreement for China
BOSTON EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies,...
View ArticleBioMotiv and Takeda Pharmaceutical Company Enter into Strategic Partnership
CLEVELAND & OSAKA, Japan Takeda Pharmaceutical Company Limited (“Takeda”) and BioMotiv, LLC, the therapeutic accelerator company associated with The Harrington Project for Discovery &...
View Article経口薬OTEZLA®(アプレミラスト)が中等度から重度の尋常性乾癬患者の治療薬として米食品医薬品局の承認を取得
米ニュージャージー州サミット (ビジネスワイヤ) — セルジーン・コーポレーション(NASDAQ:...
View Article美国食品药品管理局核准Oral OTEZLA® (apremilast)用于治疗中重度斑块状银屑病患者
新泽西州萨米特 (美国商业资讯) — Celgene Corporation (NASDAQ: CELG)今天宣布,美国食品药品管理局(FDA)已核准该公司的磷酸二酯酶4 (PDE4) 选择性抑制剂口服制剂OTEZLA®...
View ArticleCoalition for Affordable Care Website Launched, Heralding Indian Prime...
WASHINGTON As India’s Prime Minister Narendra Modi readies for his first encounter with President Barack Obama next week, the Indian pharmaceutical industry, U.S. health care providers and life...
View Article